Spinocerebellar ataxias (SCA) are rare inherited neurodegenerative disorders marked by increasing issues with gait, balance, limb coordination, and speech. At present, there is no scale available for measuring the progression…
ISPOR US is moving south this year, taking place in Atlanta, May 5th to 8th. Broadstreet is pleased to be involved in twelve studies being presented on subjects ranging from…
ISPOR US is moving south this year, taking place in Atlanta, May 5th to 8th. Broadstreet is pleased to be involved in twelve studies being presented on subjects ranging from…
February 29th is Rare Disease Day; rare diseases affect fewer than 1 in 2,000 people,1 while ultra-rare diseases affect fewer than 1 in 50,000 people.2 Globally, around 300 million people…
By Shelagh M. Szabo Interest in the inclusion of patient perspectives in health research is growing across all aspects of the field, including health technology assessment (HTA). A recent international…
Broadstreet will be presenting our research on a number of projects at the ISPOR Europe conference in Copenhagen this year. As well, we are looking forward to learning what’s new…
The FDA is continually publishing and updating guidance to allow for and encourage the generation of RWE specifically for regulatory decisions. Recently they issued new guidelines for industry: Considerations for…
In the conduct of network meta-analysis (NMA), guidance documents developed by the Decision Support Unit (DSU) for the National Institute for Health and Care Excellence (NICE) have been widely adopted.…
Broadstreet at ISPOR 2023 ISPOR is back in person this year, taking place in Boston between May 7th to 10th. Members of the Broadstreet team are pleased to be presenting…